Credit Suisse’s Kindred Biosciences, Inc. KIN Stock Holding History

Credit Suisse’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-10,305	Closed	-$44K	–	4686
2020 Q4	$44K	Buy	+10,305	New	+$41.9K	﹤0.01%	4264
2017 Q4	–	Sell	-16,965	Closed	-$133K	–	4285
2017 Q3	$133K	Buy	+16,965	New	+$127K	﹤0.01%	4035
2016 Q1	–	Sell	-10,817	Closed	-$37K	–	4387
2015 Q4	$37K	Buy	+10,817	New	+$50.2K	﹤0.01%	4152
2015 Q3	–	Sell	-16,654	Closed	-$114K	–	4568
2015 Q2	$114K	Buy	+16,654	New	+$118K	﹤0.01%	4364
2015 Q1	–	Sell	-26,450	Closed	-$197K	–	4653
2014 Q4	$197K	Sell	26,450 -28,914	-52%	-$245K	﹤0.01%	4275
2014 Q3	$512K	Buy	+55,364	New	+$748K	﹤0.01%	3625

Other funds holding KIN

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BCPEMI

Bain Capital Public Equity Management II Boston, Massachusetts $62.1M AUM 25.46% 1-Year Est. Return

Credit Suisse's KIN Position: Q1 2021 in Review

Credit Suisse sold out of Kindred Biosciences, Inc. (KIN) in Q1 2021, closing a stake of 10,305 shares — an estimated $44K sold.

Credit Suisse first reported a position in KIN in Q3 2014 and held it in 6 quarters. The position peaked at $512K in Q3 2014. 84 funds tracked by Wall St. Rank hold KIN as of Q1 2021.

Credit Suisse reported no remaining Kindred Biosciences, Inc. position as of Q1 2021 after selling out during the quarter.
Credit Suisse sold 10,305 Kindred Biosciences, Inc. shares in Q1 2021, an estimated $44K.
Credit Suisse first reported a position in Kindred Biosciences, Inc. in Q3 2014 and held it in 6 quarters.
Credit Suisse's Kindred Biosciences, Inc. position peaked at $512K in Q3 2014.
84 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q1 2021.

Based on Credit Suisse's 13F filing for Q1 2021, filed 14 May 2021.